ReviewCancers2025
The Washout of Hepatocellular Carcinoma at Portal Venous Phase vs. Equilibrium Phase: Radiological and Clinicopathological Implication.
Review in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Mechanical bowel displacement to enable safe microwave ablation of a peripheral hepatic tumor in Chilaiditi anatomy.Radiology case reports · 2026Article
- Temporal Differentiation of Nonperipheral Washout Refines Prognostic Stratification in HCC.Liver international : official journal of the International Association for the Study of the Liver · 2026Article
- Baseline CT imaging features combined with clinical indicators predict prognosis in unresectable HCC treated with HAIC plus targeted therapy and immunotherapy.Abdominal radiology (New York) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Portal venous or late (equilibrium) phase washout is one of the well-known major imaging features of hepatocellular carcinoma (HCC). However, these two washouts stand for distinct intratumoral pathophysiological states and should be considered separately. Positive portal venous phase (PVP) washout has been shown to be related to high grade HCC, poor post operative survival rate, and positive PD-L1 or VETC. In contrast, there is indirect evidence that negative washout at equilibrium or late phase (EqP) may be related to biliary/stem cell subtype, which is biologically aggressive, and associated with an immune hot tumor microenvironment. Thus, although these two washouts represent different intratumoral pathophysiological conditions, both are closely related to biological aggressiveness or tumor microenvironment, which may be associated with the response to systemic therapies or post-surgical survival. In contemporary practice, gadoxetate-enhanced MRI restricts washout assessment in the PVP, whereas extracellular agent CT permits assessment in both the PVP and EqP; accordingly, this review addresses PVP washout on CT or extracellular agent MRI, PVP washout on gadoxetate-enhanced MRI, and EqP washout on CT. When washout information is integrated with other clinico-radiological features, more precise prediction of patient survival or response to systemic therapies would become possible in the future.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.